Five-Year Survival and Correlates among Patients with Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated with Nivolumab.
Times cited: 21
Combined nivolumab and ipilimumab in melanoma metastatic to the brain.
New England Journal of Medicine.
Times cited: 180
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.
Journal of Clinical Oncology.
Times cited: 862